Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Drugs to combat hospital-acquired infections 'increase risk of complications'

  • Comment

Researchers have warned that drugs used to tackle hospital-acquired infections (HAI) can increase the risk of post-operative complications.

The specific nature of different types of surgery should be taken into account before new antibiotic regimes are introduced, warned experts based at Addenbrooke’s Hospital in Cambridge.

Their study - which followed the introduction of new antibiotic regimes to combat HAIs such as C difficile - was published in the November issue of the British Journal of Urology International.

The team, led by Prof David Neal, found the risks associated with certain procedures increased significantly. For instance, patients undergoing a standard surgical procedure to diagnose prostate cancer developed more than five times as many infective complications when a new regime was introduced.

Prof Neal said proposed changes to antibiotic policies should be linked to strong clinical evidence because they “may potentially result in significant ill health and potential harm”.

 

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.